Medtronic product removed from market in Australia, which is now investigating its use

Medtronic has pulled one of its most controversial products, Infuse Bone Graft, off the market in Australia as regulators there investigate why the company was widely selling it without a required safety component.The market withdrawal happened after a former Medtronic employee told regulators that the Minnesota-run medical device company sold Infuse’s bone graft component without the titanium LT-Cage cage designed to hold it in check.Medtronic spokesman Ben Petok said the company’s withdrawal of Infuse from Australia in March had nothing to do with safety issues. The company hopes to return w…

Read More

HEDGE accordingly